Femasys Inc. Partners with Carolinas Fertility Institute to Offer Innovative FemaSeed® Treatment

Reuters

2025/06/11

<a href="https://laohu8.com/S/FEMY">Femasys Inc</a>. Partners with Carolinas Fertility Institute to Offer Innovative FemaSeed® Treatment

Femasys Inc., a leading company in women's health innovation, has announced a partnership with Carolinas Fertility Institute $(CFI)$, recognized as one of America's top fertility clinics. This collaboration will see CFI offering Femasys' FemaSeed® intratubal insemination product across its network in North Carolina. This partnership aims to provide patients with a first-line fertility treatment option that is less invasive and more cost-effective than traditional IVF. Kathy Lee-Sepsick, CEO and Founder of Femasys, highlighted the significance of this partnership in expanding treatment offerings and supporting patients earlier in their fertility journey. Dr. Tamer Yalcinkaya, Founder and Medical Director of CFI, expressed enthusiasm for incorporating FemaSeed® as it aligns with the clinic's mission to deliver advanced, affordable, and less invasive fertility care.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Femasys Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9466539-en) on June 11, 2025, and is solely responsible for the information contained therein.

应版权方要求，你需要登录查看该内容

登录 / 注册

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2542058210"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2542058210\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2542058210?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-06-11 21:00","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2542058210","market":"us","top_or_hot":-1,"title":"Femasys Inc. Partners with Carolinas Fertility Institute to Offer Innovative FemaSeed® Treatment","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      <a href=\"https://laohu8.com/S/FEMY\">Femasys Inc</a>. Partners with Carolinas Fertility Institute to Offer Innovative FemaSeed® Treatment\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Femasys Inc., a leading company in women's health innovation, has announced a partnership with Carolinas Fertility Institute <a href=\"https://laohu8.com/S/CFI\">$(CFI)$</a>, recognized as one of America's top fertility clinics. This collaboration will see CFI offering Femasys' FemaSeed® intratubal insemination product across its network in North Carolina. This partnership aims to provide patients with a first-line fertility treatment option that is less invasive and more cost-effective than traditional IVF. Kathy Lee-Sepsick, CEO and Founder of Femasys, highlighted the significance of this partnership in expanding treatment offerings and supporting patients earlier in their fertility journey. Dr. Tamer Yalcinkaya, Founder and Medical Director of CFI, expressed enthusiasm for incorporating FemaSeed® as it aligns with the clinic's mission to deliver advanced, affordable, and less invasive fertility care.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Femasys Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9466539-en) on June 11, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Femasys Inc. Partners with Carolinas Fertility Institute to Offer Innovative FemaSeed® Treatment</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFemasys Inc. Partners with Carolinas Fertility Institute to Offer Innovative FemaSeed® Treatment\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-06-11 21:00</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      <a href=\"https://laohu8.com/S/FEMY\">Femasys Inc</a>. Partners with Carolinas Fertility Institute to Offer Innovative FemaSeed® Treatment\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Femasys Inc., a leading company in women's health innovation, has announced a partnership with Carolinas Fertility Institute <a href=\"https://laohu8.com/S/CFI\">$(CFI)$</a>, recognized as one of America's top fertility clinics. This collaboration will see CFI offering Femasys' FemaSeed® intratubal insemination product across its network in North Carolina. This partnership aims to provide patients with a first-line fertility treatment option that is less invasive and more cost-effective than traditional IVF. Kathy Lee-Sepsick, CEO and Founder of Femasys, highlighted the significance of this partnership in expanding treatment offerings and supporting patients earlier in their fertility journey. Dr. Tamer Yalcinkaya, Founder and Medical Director of CFI, expressed enthusiasm for incorporating FemaSeed® as it aligns with the clinic's mission to deliver advanced, affordable, and less invasive fertility care.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Femasys Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9466539-en) on June 11, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4585","symbol_name":"ETF&股票定投概念","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250611:nNDL7ZXD0t:1","article_id":"2542058210","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2542058210","pubTimestamp":1749646836,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Femasys Inc., a leading company in women's health innovation, has announced a partnership with Carolinas Fertility Institute , recognized as one of America's top fertility clinics. This collaboration will see CFI offering Femasys' FemaSeed intratubal insemination product across its network in North Carolina. This partnership aims to provide patients with a first-line fertility treatment option that is less invasive and more cost-effective than traditional IVF. Kathy Lee-Sepsick, CEO and Founder of Femasys, highlighted the significance of this partnership in expanding treatment offerings and supporting patients earlier in their fertility journey. Dr. Tamer Yalcinkaya, Founder and Medical Director of CFI, expressed enthusiasm for incorporating FemaSeed as it aligns with the clinic's mission to deliver advanced, affordable, and less invasive fertility care.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provid","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4585":"ETF&股票定投概念","NDAQ":"纳斯达克OMX交易所","BK4539":"次新股","IE00BGHQF748.EUR":"GUINNESS GLOBAL MONEY MANAGERS \"C\" (EUR) ACC","IE00BKPKM429.USD":"NEUBERGER BERMAN GLOBAL SUSTAINABLE EQUITY \"A\" (USD) ACC","BK4588":"碎股","LU2210150020.SGD":"Natixis Thematics Subscription Economy R/A SGD","FEMY":"Femasys Inc","IE00B64PRP62.GBP":"GUINNESS GLOBAL MONEY MANAGERS \"C\" (GBP) ACC","IE00B3QW5Z07.USD":"GUINNESS GLOBAL MONEY MANAGERS \"C\" (USD) ACC","LU2210149790.SGD":"Natixis Thematics Subscription Economy R/A SGD-H","BK4112":"金融交易所和数据","BK4584":"避孕概念","LU2095319765.USD":"Natixis Thematics Subscription Economy R/A USD","BK4082":"医疗保健设备"},"translate_title":"Femasys Inc.与卡罗莱纳州生育研究所合作提供创新的FemaSeed®病治疗","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"FEMY":0.9,"NDAQ":0.9},"content_text":"Femasys Inc. Partners with Carolinas Fertility Institute to Offer Innovative FemaSeed® Treatment\n    \n\n        Femasys Inc., a leading company in women's health innovation, has announced a partnership with Carolinas Fertility Institute $(CFI)$, recognized as one of America's top fertility clinics. This collaboration will see CFI offering Femasys' FemaSeed® intratubal insemination product across its network in North Carolina. This partnership aims to provide patients with a first-line fertility treatment option that is less invasive and more cost-effective than traditional IVF. Kathy Lee-Sepsick, CEO and Founder of Femasys, highlighted the significance of this partnership in expanding treatment offerings and supporting patients earlier in their fertility journey. Dr. Tamer Yalcinkaya, Founder and Medical Director of CFI, expressed enthusiasm for incorporating FemaSeed® as it aligns with the clinic's mission to deliver advanced, affordable, and less invasive fertility care.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Femasys Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9466539-en) on June 11, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}